PRA Expands Operations in China

New Beijing Office to Strengthen Regional Service

News provided by

Aug 22, 2012, 09:00 ET

RALEIGH, N.C., Aug. 22, 2012 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces the opening of a second office in China to accommodate our continued expansion in China and the Asia Pacific region. PRA established our first China office in Shanghai in 2005. PRA's new facility, conveniently located in the central business district of Beijing, will enhance our local project teams' ability to meet the growing demand for our clinical drug development programs and collocate us with many of our key clients in Beijing.

"As the demand for clinical sites in Asia increase, we continually strive to strengthen our existing operations in China and the Asia Pacific region," said Helen Neal, Regional Director – Clinical Operations, Asia Pacific, Middle East, and North Africa. "By adding more professional staff and locations, we can give our clients greater access to these critical markets and geography. In addition to our expansion in China, we continue to increase our presence into new and emerging Southeast Asian regions for access to patients and resources."

"We are very excited about our continued expansion into China," said Kent Thoelke, Executive Vice President, Scientific & Medical Affairs. "In order for global drug development to continue successfully, the need to access patients at high-quality ICH/GCP sites in emerging regions like China is critical. PRA's expansion in this market gives us the ability to bring exciting new clinical trials to a much broader market in China, while providing even greater patient access to our clients and sponsor companies."

PRA has been operating in China for over 10 years and also has an office in Hong Kong. Additional Asia Pacific locations include South Korea, Taiwan, Thailand, Singapore, Australia, New Zealand, and India.

About PRA
PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email [email protected] or call our Global Headquarters.

SOURCE PRA